PL332038A1 - Method of treating postmenopausal diseases including osteoporosis - Google Patents

Method of treating postmenopausal diseases including osteoporosis

Info

Publication number: PL332038A1
Authority: PL; Poland
Prior art keywords: diseases including; including osteoporosis; treating postmenopausal; postmenopausal diseases; treating
Prior art date: 1996-09-06

Application number

PL97332038A

Inventor

Jeremy N Bradbeer

Maxine Gowen

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-06

Filing date

1997-09-03

Publication date

1999-08-16

1997-09-03 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1999-08-16 Publication of PL332038A1 publication Critical patent/PL332038A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)
Saccharide Compounds (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL97332038A 1996-09-06 1997-09-03 Method of treating postmenopausal diseases including osteoporosis PL332038A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2543996P	1996-09-06	1996-09-06
US5066697P	1997-06-24	1997-06-24

Publications (1)

Publication Number	Publication Date
PL332038A1 true PL332038A1 (en)	1999-08-16

Family

ID=26699738

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL97332038A PL332038A1 (en)	1996-09-06	1997-09-03	Method of treating postmenopausal diseases including osteoporosis
PL97332278A PL332278A1 (en)	1996-09-06	1997-09-03	Novel methods

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL97332278A PL332278A1 (en)	1996-09-06	1997-09-03	Novel methods

Country Status (16)

Country	Link
EP (2)	EP0929216A4 (en)
JP (2)	JP2002515047A (en)
KR (2)	KR20000068472A (en)
CN (2)	CN1236299A (en)
AR (1)	AR008155A1 (en)
AU (2)	AU4247397A (en)
BR (2)	BR9711681A (en)
CA (2)	CA2264943A1 (en)
CO (2)	CO5070658A1 (en)
CZ (1)	CZ76699A3 (en)
IL (1)	IL128645A0 (en)
NO (2)	NO991096D0 (en)
PL (2)	PL332038A1 (en)
TR (2)	TR199900506T2 (en)
TW (1)	TW411273B (en)
WO (2)	WO1998009519A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998034608A1 (en) *	1997-02-11	1998-08-13	Novo Nordisk A/S	Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) *	1998-12-09	1999-02-03	Orion Corp	Agent for lowering endothelin levels
DE19905961A1 (en) *	1999-02-12	2000-08-17	Stefan Neubauer	Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction
US6528681B2 (en) *	2000-04-05	2003-03-04	Bristol-Meyers Squibb Pharma Company	Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
IL145876A0 (en)	2000-10-17	2002-07-25	Pfizer Prod Inc	Methods and kits for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2196003A (en) *	1986-09-11	1988-04-20	Nat Res Dev	Iodo-and bromo-tamoxifen derivatives
DK0660821T3 (en) *	1992-09-15	1998-09-21	Merrell Pharma Inc	Non-metabolizable clomiphene analogs for the treatment of tamoxifen-resistant tumors
US5681835A (en) *	1994-04-25	1997-10-28	Glaxo Wellcome Inc.	Non-steroidal ligands for the estrogen receptor
US5604248A (en) *	1994-05-05	1997-02-18	Eli Lilly And Company	Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) *	1994-05-23	1995-11-28	Stromberg; Brent V.	Method of treating peripheral vasoconstriction with tamoxifen citrate
AU6277396A (en) *	1995-06-07	1996-12-30	Neorx Corporation	Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS
US6069175A (en) *	1996-11-15	2000-05-30	Pfizer Inc.	Estrogen agonist/antagonists treatment of atherosclerosis

1997
- 1997-08-29 AR ARP970103968A patent/AR008155A1/en unknown
- 1997-09-03 AU AU42473/97A patent/AU4247397A/en not_active Abandoned
- 1997-09-03 BR BR9711681A patent/BR9711681A/en not_active Application Discontinuation
- 1997-09-03 EP EP97940773A patent/EP0929216A4/en not_active Withdrawn
- 1997-09-03 PL PL97332038A patent/PL332038A1/en unknown
- 1997-09-03 WO PCT/US1997/015474 patent/WO1998009519A1/en not_active Ceased
- 1997-09-03 WO PCT/US1997/015475 patent/WO1998009619A1/en not_active Ceased
- 1997-09-03 CA CA002264943A patent/CA2264943A1/en not_active Abandoned
- 1997-09-03 PL PL97332278A patent/PL332278A1/en unknown
- 1997-09-03 KR KR1019997001860A patent/KR20000068472A/en not_active Withdrawn
- 1997-09-03 TR TR1999/00506T patent/TR199900506T2/en unknown
- 1997-09-03 CA CA002264775A patent/CA2264775A1/en not_active Abandoned
- 1997-09-03 TR TR1999/00504T patent/TR199900504T2/en unknown
- 1997-09-03 CZ CZ99766A patent/CZ76699A3/en unknown
- 1997-09-03 IL IL12864597A patent/IL128645A0/en unknown
- 1997-09-03 JP JP51283898A patent/JP2002515047A/en active Pending
- 1997-09-03 JP JP51283798A patent/JP2002515046A/en active Pending
- 1997-09-03 EP EP97942388A patent/EP0927029A4/en not_active Withdrawn
- 1997-09-03 BR BR9711676A patent/BR9711676A/en not_active Application Discontinuation
- 1997-09-03 KR KR1019997001861A patent/KR20000068473A/en not_active Withdrawn
- 1997-09-03 CN CN97199492A patent/CN1236299A/en active Pending
- 1997-09-03 CN CN97199493A patent/CN1236313A/en active Pending
- 1997-09-03 AU AU44097/97A patent/AU4409797A/en not_active Abandoned
- 1997-09-04 CO CO97051289A patent/CO5070658A1/en unknown
- 1997-09-04 CO CO97051287A patent/CO4920218A1/en unknown
- 1997-12-11 TW TW086112930A patent/TW411273B/en active
1999
- 1999-03-05 NO NO991096A patent/NO991096D0/en not_active Application Discontinuation
- 1999-03-05 NO NO991097A patent/NO991097D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU4409797A (en)	1998-03-26
BR9711681A (en)	1999-08-24
EP0929216A1 (en)	1999-07-21
CO5070658A1 (en)	2001-08-28
AU4247397A (en)	1998-03-26
WO1998009619A1 (en)	1998-03-12
TR199900504T2 (en)	1999-06-21
WO1998009519A1 (en)	1998-03-12
CZ76699A3 (en)	1999-08-11
IL128645A0 (en)	2000-01-31
AR008155A1 (en)	1999-12-09
CN1236299A (en)	1999-11-24
EP0929216A4 (en)	2001-04-04
NO991097L (en)	1999-03-05
EP0927029A4 (en)	2001-06-13
JP2002515046A (en)	2002-05-21
NO991096L (en)	1999-03-05
CA2264943A1 (en)	1998-03-12
TW411273B (en)	2000-11-11
BR9711676A (en)	1999-08-24
CA2264775A1 (en)	1998-03-12
NO991096D0 (en)	1999-03-05
KR20000068473A (en)	2000-11-25
CN1236313A (en)	1999-11-24
EP0927029A1 (en)	1999-07-07
KR20000068472A (en)	2000-11-25
CO4920218A1 (en)	2000-05-29
JP2002515047A (en)	2002-05-21
TR199900506T2 (en)	1999-07-21
NO991097D0 (en)	1999-03-05
PL332278A1 (en)	1999-08-30

Publication	Publication Date	Title
GB9407135D0 (en)	1994-06-01	Treatment of osteoporosis
PL328831A1 (en)	1999-02-15	Combined treatment of osteoporosis
GB9617780D0 (en)	1996-10-02	Method of treatment
SG50018A1 (en)	1998-06-15	Method for developing treatment
PL339910A1 (en)	2001-01-15	Method of treating alzheimer disease
GB9715295D0 (en)	1997-09-24	Novel method of treatment
GB9712866D0 (en)	1997-08-20	Novel method of treatment
GB9707693D0 (en)	1997-06-04	Novel method of treatment
GB9715298D0 (en)	1997-09-24	Novel method of treatment
GB9715306D0 (en)	1997-09-24	Novel method of treatment
PL332038A1 (en)	1999-08-16	Method of treating postmenopausal diseases including osteoporosis
IL124786A0 (en)	1999-01-26	Method for treating pain
ZA973988B (en)	1998-11-09	Method of treatment
GB9618341D0 (en)	1996-10-16	Method of treatment
PL320564A1 (en)	1997-10-13	Therapeutic set for treating osteoporosis
GB9507825D0 (en)	1995-05-31	Method of treatment
GB2294880B (en)	1998-07-08	Method of treating turf
GB9415902D0 (en)	1994-09-28	Method of treatment
IL120955A0 (en)	1997-09-30	Treatment of osteoporosis
GB9407335D0 (en)	1994-06-08	Method of treatment
GB9414652D0 (en)	1994-09-07	Method of treatment
GB9505895D0 (en)	1995-05-10	Apparatus for treating shoes
EG24199A (en)	2008-10-19	Novel method of treatment
EG24157A (en)	2008-08-20	Novel method of treatment
GB9600888D0 (en)	1996-03-20	Method of treatment